All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

7

Reset

7 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • RO7204239Phase 33 trials

    Roche (Genentech) · Obesity, Overweight, Overweight With One Weight Related Comorbidity

  • SalanersenBIIB115Phase 33 trials

    Biogen · Muscular Atrophy, Spinal, Spinal Muscular Atrophy

  • BHV-2000Taldefgrobep, BMS-986089Phase 32 trials

    Biohaven Pharmaceuticals, Inc. · Spinal Muscular Atrophy, Neuromuscular Diseases, SMA

  • NMD670Phase 23 trials

    NMD Pharma A/S · Myasthenia Gravis, Myasthenia Gravis, MuSK, Charcot-Marie-Tooth Disease

  • ARGX-119Phase 21 trial

    argenx · Spinal Muscular Atrophy (SMA)

  • GB221Phase 21 trial

    Gemma Biotherapeutics · Spinal Muscular Atrophy Type I

  • NIDO-361Phase 21 trial

    Nido Biosciences, Inc. · Spinal and Bulbar Muscular Atrophy, Kennedy's Disease

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.